| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | GMP, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Powder |
| Purity: | >98% |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Ursodeoxycholic acid, chemical name 3a, 7 β- Dihydroxy-5 β- Cholesterane-24-acid, an organic compound, odorless and bitter in taste. In medicine, it is used to increase bile acid secretion, change bile components, reduce cholesterol and cholesterol fat in bile, and help cholesterol in gallstones gradually dissolve.
It is used to treat cholelithiasis, cholestatic liver disease, fatty liver, hepatitis, toxic liver disorder, cholecystitis, cholangitis, biliary dyspepsia, bile reflux gastritis, eye diseases, etc.
On December 5, 2022, researchers at the University of Cambridge, UK, published an article in the journal Nature, saying that the existing drug UDCA can close the door for viruses to enter cells and protect us from pneumonia. Importantly, because the drug acts on our cells, it is not affected by virus mutations, and should be effective even if new mutations occur.
In addition, UDCA has been used clinically for many years, so we know that it is safe and well tolerated, and this tablet is cheap, can be produced rapidly in large quantities, and is easy to store or transport.
At the same time, Novi Medical researchers published an article in Shanghai in 2022-12-06, suggesting that the ACE2 receptor should be turned off to prevent all mutations. The researchers stressed that we are optimistic that this drug may become an important weapon against pneumonia.
|
English name: Ursodeoxic Acid CAS No. 128-13-2 EINE No. 204-879-3 Molecular formula: C24H40O4 Molecular weight: 392.57200 Precise mass: 392.29300 PSA:77.76000 LogP:4.47790 |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}